The equity of GUANZE MEDICAL(02427) is highly concentrated.

GUANZE MEDICAL (02427) Announces that the company has noted that the Securities and Futures Commission (SFC) of Hong Kong has issued a notice on May 27, 2026 (SFC Notice). The SFC recently conducted an inquiry on the equity distribution of the company. The inquiry results showed that on May 13, 2026, 20 shareholders collectively held 894 million shares, equivalent to 94.13% of the issued shares. Therefore, only 55.7631 million shares (equivalent to 5.87% of the issued shares) were held by other shareholders. The share price has increased by 967.9% from HK$0.53 on January 7, 2026 to HK$5.66 on May 13, 2026. On May 26, 2026, the share price closed at HK$5.46, a 930.2% increase from the closing price of HK$0.53 on January 7, 2026. Based on available information and after conducting all reasonable inquiries as per the directors' knowledge, the company confirms that as of May 13, 2026 and the date of this announcement, at least 25% of the issued shares are held by the public, and the company is able to comply with the public float requirements under the Listing Rules of the Hong Kong Stock Exchange.